SUMMIT NORTH WEST LIMITED

Company number 13478674 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SUMMIT NORTH WEST LIMITED - Analysis Report

Company Number: 13478674

Analysis Date: 2025-07-20 16:06 UTC

Financial Health Assessment of SUMMIT NORTH WEST LIMITED


1. Financial Health Score: B

Explanation:
The company demonstrates a solid financial foundation with positive net assets, consistent working capital, and no overdue filings, suggesting good financial discipline and operational stability. However, there is a slight decline in total net assets and current assets over recent years, which warrants monitoring. The presence of a director loan, though repaid promptly, also suggests reliance on internal financing. Overall, the company's financial health is good but shows early symptoms that require vigilance to maintain a healthy trajectory.


2. Key Vital Signs

Metric 2024 (£) 2023 (£) Interpretation
Fixed Assets 171 341 Very low fixed assets, typical for a micro entity; minimal investment in long-term assets.
Current Assets 8,292 11,418 Healthy short-term assets but decreased by ~27%, indicating reduced liquidity or lower receivables/cash.
Current Liabilities 1,287 4,188 Significant reduction in short-term obligations, which improves liquidity.
Net Current Assets 7,005 7,230 Stable positive working capital, indicating sufficient liquid resources to cover short-term debts.
Net Assets (Shareholder Funds) 7,176 7,571 Slight decrease (~5%), but remains positive, reflecting retained earnings and capital base.
Director Loan (Current Asset) 6,647 (repaid post year-end) N/A Reliance on director loan to manage cash flow, though it was repaid within 9 months, showing good resolution of temporary liquidity needs.
Employee Count 1 1 Very small workforce, consistent with micro entity status.

Interpretation of Vital Signs:
The company exhibits a healthy cash flow profile with positive net current assets, ensuring operational liquidity. The symptom of declining current assets could indicate reduced incoming cash or lower business activity, but this is balanced by a reduction in liabilities. The director loan presence signals a temporary cash flow patch, which was corrected promptly, akin to a patient taking medication to stabilize a symptom.


3. Diagnosis

  • Liquidity: The company maintains a strong liquidity position with net current assets comfortably positive (~£7,000), meaning it can meet short-term obligations without distress.
  • Solvency: Positive net assets reflect solvency and a buffer against financial shocks, indicating no immediate risk of insolvency.
  • Operational Scale: Being a micro-entity with only one employee and minimal fixed assets suggests a lean operation, likely consultancy-based consistent with SIC code 70229.
  • Financial Trends: The slight reduction in assets and net assets over the last financial year is a mild symptom of shrinking operations or cautious scaling back but not a critical issue.
  • Governance and Compliance: All statutory filings are up to date, indicating good corporate governance and compliance discipline.
  • Financial Structure: Reliance on director loans, though temporary and repaid, hints at potential cash flow management issues but also indicates strong director support.

Overall, the company is in good financial health with stable liquidity and solvency, but the mild downward trend in assets and the use of director loans suggest careful monitoring is advised to avoid future financial strain.


4. Recommendations

  1. Cash Flow Management:
    Enhance cash flow forecasting to avoid reliance on director loans. Consider building a small cash reserve to cushion short-term liquidity fluctuations.

  2. Asset Optimization:
    Review current assets composition and seek to increase liquid assets or reduce slow-moving receivables to improve working capital quality.

  3. Growth Strategy:
    Evaluate opportunities to increase business volume or diversify client base to reverse the slight decrease in net assets and current assets.

  4. Financial Monitoring:
    Implement regular financial health checks quarterly to detect early symptoms of distress such as declining assets or rising liabilities.

  5. Cost Control:
    Maintain the lean cost structure but ensure investment in necessary resources that can drive growth and operational efficiency.

  6. Director Loan Transparency:
    Continue transparent tracking and timely repayment of director loans to maintain stakeholder confidence and clean financial statements.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.